Android app Apple app link

Teva Pharmaceutical Industries Limited (TEVA) Analyst Forecast

NYSE Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$34.10

$1.03 (3.1%)
Last update: 09:50 AM EST
Day's range
$32.35
Day's range
$34.11

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
01/30/2026 Barclays Glen Santangelo $38.00 $33.07   14.91%
11/06/2025 Goldman Sachs Matt Dellatorre $28.00 $24.40   14.78%
12/18/2024 UBS Ashwani Verma $28.00 $21.20   32.08%
12/18/2024 Barclays Balaji Prasad $28.00 $21.20   32.08%
10/22/2024 Barclays Balaji Prasad $25.00 $18.38   36.02%
10/01/2024 Bank of America Securities Jason Gerberry $22.00 $17.75   23.94%
09/03/2024 UBS Ashwani Verma $26.00 $18.43   41.11%
08/28/2024 Piper Sandler David Amsellem $23.00 $18.62   23.56%
08/01/2024 Barclays Balaji Prasad $22.00 $17.43   26.22%
07/10/2024 Argus Research Jasper Hellweg $20.00 $15.81   26.5%
07/10/2024 UBS Ashwani Verma $24.00 $15.81   51.8%
06/05/2024 Barclays Balaji Prasad $21.00 $16.63   26.28%
05/23/2024 Barclays Balaji Prasad $20.00 $16.76   19.33%
05/13/2024 Piper Sandler David Amsellem $20.00 $16.90   18.38%
02/11/2024 Piper Sandler David Amsellem $19.00 $12.01   58.2%
01/22/2024 Jefferies Glen Santangelo $14.00 $11.99   16.76%
06/13/2022 UBS Ashwani Verma $10.00 $7.89   26.74%
04/19/2022 Barclays Balaji Prasad $13.00 $9.79   32.79%

Teva Pharmaceutical Industries Limited FAQ's

Teva Pharmaceutical Industries Limited has been rated by research analysts at Barclays, Scotiabank, Truist Financial, Jefferies, Piper Sandler, Goldman Sachs in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.